Abstract
Objectives: To describe trends in STD visits to physicians in private practice in Peru over a 15 year period and in the patterns of treatments used for STD.
Methods: IMS Health conducts for pharmaceutical marketing purposes surveys of a random cluster sample of 1.63% of practising physicians in Peru, stratified by region and specialty. Physicians record details of diagnoses and treatments for all patients seen during a 7 day period every 6 months. Data collected on selected STD syndromes were retrospectively reviewed over a 15 year period.
Results: The number of first visits for pelvic inflammatory disease (PID) and trichomoniasis, and total visits for genital herpes increased from 1983–5 to 1996–7; while first visits for gonorrhoea and total visits for syphilis have changed little in recent years. Treatment for gonorrhoea usually involved the use of spectinomycin or an aminoglycoside only. Treatments offered for PID were remarkably inadequate and for trichomoniasis often involved products not known to be effective for trichomoniasis or other causes of vaginal discharge.
Conclusions: This form of active surveillance provides information potentially useful to guide policies for prevention and management of STDs and HIV infections in developing countries.
Full Text
The Full Text of this article is available as a PDF (323.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Becker T. M., Blount J. H., Douglas J., Judson F. N. Trends in molluscum contagiosum in the United States, 1966-1983. Sex Transm Dis. 1986 Apr-Jun;13(2):88–92. doi: 10.1097/00007435-198604000-00007. [DOI] [PubMed] [Google Scholar]
- Becker T. M., Stone K. M., Alexander E. R. Genital human papillomavirus infection. A growing concern. Obstet Gynecol Clin North Am. 1987 Jun;14(2):389–396. [PubMed] [Google Scholar]
- Brackbill R. M., Sternberg M. R., Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect. 1999 Jan-Feb;31(1):10–15. [PubMed] [Google Scholar]
- Dallabetta G. A., Gerbase A. C., Holmes K. K. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S1–11. [PubMed] [Google Scholar]
- Garcia P. J., Gotuzzo E., Hughes J. P., Holmes K. K. Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S153–S158. [PubMed] [Google Scholar]
- Grimes D. A., Blount J. H., Patrick J., Washington A. E. Antibiotic treatment of pelvic inflammatory disease. Trends among private physicians in the United States, 1966 through 1983. JAMA. 1986 Dec 19;256(23):3223–3226. doi: 10.1001/jama.256.23.3223. [DOI] [PubMed] [Google Scholar]
- Kilmarx P. H., Limpakarnjanarat K., Supawitkul S., Korattana S., Young N. L., Parekh B. S., Respess R. A., Mastro T. D., St Louis M. E. Mucosal disruption due to use of a widely-distributed commercial vaginal product: potential to facilitate HIV transmission. AIDS. 1998 May 7;12(7):767–773. doi: 10.1097/00002030-199807000-00013. [DOI] [PubMed] [Google Scholar]
- Wawer M. J., Sewankambo N. K., Serwadda D., Quinn T. C., Paxton L. A., Kiwanuka N., Wabwire-Mangen F., Li C., Lutalo T., Nalugoda F. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet. 1999 Feb 13;353(9152):525–535. doi: 10.1016/s0140-6736(98)06439-3. [DOI] [PubMed] [Google Scholar]